research:learning_effective_clinical_treatment_pathways_from_data
Differences
This shows you the differences between two versions of the page.
| Next revision | Previous revision Next revision Both sides next revision | ||
|
research:learning_effective_clinical_treatment_pathways_from_data [2015/11/10 01:32] rohit_vashisht created |
research:learning_effective_clinical_treatment_pathways_from_data [2017/10/27 14:38] rohit_vashisht |
||
|---|---|---|---|
| Line 1: | Line 1: | ||
| - | ====== <Learning Effective Clinical Treatment Pathways from Data> ====== | + | ====== Learning Effective Clinical Treatment Pathways from Data ====== |
| <WRAP box justify round> | <WRAP box justify round> | ||
| - | **Objective:** //<summarize study objective>// | + | **Objective:** //Treatment guidelines for the management of type-2 diabetes mellitus (T2DM) are controversial because existing evidence from randomized clinical trials do not address many important clinical questions. An earlier investigation led by Observational Health Data Science (OHDSI) group reveled heterogeneity in the practice of both first and second line treatment choices in T2D with respect to established clinical guidelines. The choice of an optimal second-line drug among available options (Sulfonylureas, DPP4-Inhibitors, Thiazolidinediones) remains ambiguous. In this study, we seek to compare Sulfonylurea, DPP4-Inhibitors, and Thiazolidinediones when prescribed after Metformin for outcomes related to reduction in HbA1c < 7%, events related to Myocardial Infarction, Kidney and Eye related disorders within OHDSI network.// |
| **Rationale:** //<summarize study rationale>// | **Rationale:** //<summarize study rationale>// | ||
| - | **Project Lead(s):** //<initial proposers, list may grow>// | + | **Project Lead(s):** //Dr. Nigam Shah// |
| - | **Coordinating Institution(s):** //<your institution>// | + | **Coordinating Institution(s):** //Stanford University// |
| ** Additional Participants:** //<usually blank initially, list will grow as individuals are added who are not project leads>// | ** Additional Participants:** //<usually blank initially, list will grow as individuals are added who are not project leads>// | ||
research/learning_effective_clinical_treatment_pathways_from_data.txt ยท Last modified: 2017/12/02 13:38 by rohit_vashisht
Page Tools
